论文部分内容阅读
[目的]观察五苓散合痛泻药方加减联合硫糖铝混悬液治疗腹泻型肠易激综合征(IBS)的临床疗效。[方法]将60例IBS患者随机分为两组。治疗组30例,以五苓散合痛泻药方加减联合硫糖铝混悬液治疗;对照组30例,用西药常规治疗;[结果]治疗组和对照组显效率和总有效率比较(P<0.05)有统计学意义。[结论]五苓散合痛泻药方加减联合硫糖铝混悬液治疗腹泻型肠易激综合征临床疗效显著。
[Objective] To observe the clinical efficacy of Wu Ling San Tong Tong Xie prescription addition and subtraction combined with sucralfate suspension in the treatment of diarrhea-predominant irritable bowel syndrome (IBS). [Methods] Sixty IBS patients were randomly divided into two groups. The treatment group (30 cases) was treated with Wulingsan Gutong Recipe combined with sucralfate suspension. The control group (30 cases) was treated with western medicine routinely. [Results] The effective rate and total effective rate of the treatment group and the control group were P <0.05) was statistically significant. [Conclusion] The clinical curative effect of diarrhea-predominant irritable bowel syndrome (IBS) treated with Wuling San Tong Xie Xie decoction combined with sucralfate suspension is significant.